Skip to main content
SpringerLink
Log in
Book cover

Nasopharyngeal Cancer pp 183–192Cite as

Neoadjuvant Chemotherapy: Trials and Conclusions

  • Chapter

Part of the book series: Medical Radiology ((Med Radiol Radiat Oncol))

Megavoltage radiation therapy (RT) has been the primary treatment modality for nasopharyngeal carcinoma (NPC). With improving technology and optimization of dose fractionation, the treatment outcome has been steadily improving. However, while excellent control can be achieved for patients with early disease, further improvements of results for the majority of patients presenting with advanced locoregional diseases are still needed.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Al-Amro A, Al-Rajhi N, Khafaga Y, et al (2005) Neoadjuvant chemotherapy followed by concurrent chemo-radiation therapy in locally advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 62:508–513

    Article  PubMed  Google Scholar 

  • Al-Sarraf M, LeBlanc M, Giri PG, et al (1998a) Chemoradio-therapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J Clin Oncol 16(4):1310–1317

    CAS  PubMed  Google Scholar 

  • Al-Sarraf M, LeBlanc M, Giri PG, et al (1998b) Chemo-radiotherapy (CT-RT) vs radiotherapy (RT) in patients (PTS) with advanced nasopharyngeal cancer (NPC). Intergroup (0099) (SWOG 8892, RTOG 8817, ECOG 2388) Phase III Study: progress report. J Clin Oncol 17:385a

    Google Scholar 

  • American Joint Committee on Cancer (AJCC) (1983) Manual for staging of cancer, 2nd edn. JB Lippincott, Philadelphia, pp 25–38

    Google Scholar 

  • Bachouchi M, Cvitkovic E, Azli N, et al (1990) High complete response in advanced nasopharyngeal carcinoma with bleomycin, epirubicin, and cisplatin before radiotherapy. J Natl Cancer Inst 82(7):616–620

    Article  CAS  PubMed  Google Scholar 

  • Baujat B, Audry H, Bourhis J, et al (2006) Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients. Int J Radiat Oncol Biol Phys 64(1):47–56

    Article  CAS  PubMed  Google Scholar 

  • Chan AT, Leung SF, Ngan RK, et al (2005) Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma. J Natl Cancer Inst 97(7):536–539

    Article  CAS  PubMed  Google Scholar 

  • Chan AT, Ma BY, Lo YM, et al (2004) Phase II study of neoadju-vant carboplatin and paclitaxel followed by radiotherapy and concurrent cisplatin in patients with locoregionally advanced nasopharyngeal carcinoma: therapeutic monitoring with plasma Epstein—Barr virus DNA. J Clin Oncol 22:3053–3060

    Article  CAS  PubMed  Google Scholar 

  • Chan AT, Teo PM, Leung TW, et al (1995) A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 33(3):569–577

    Article  CAS  PubMed  Google Scholar 

  • Chen Y, Liu MZ, Liang SB, et al (2008) Preliminary results of a prospective randomized trial comparing concurrent chemo-radiotherapy plus adjuvant chemotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyn geal carcinoma in endemic regions of China. Int J Radiat Oncol Biol Phys 71(5):1356–1364

    Article  PubMed  Google Scholar 

  • Chi KH, Chang YC, Guo WY, et al (2002) A phase III study of adjuvant chemotherapy in advanced nasopharyngeal carcinoma patients. Int J Radiat Oncol Biol Phys 52(5):1238–1244

    Article  CAS  PubMed  Google Scholar 

  • Chua DT, Ma J, Sham JS, et al (2005) Long-term survival after cisplatin-based induction chemotherapy and radiotherapy for nasopharyngeal carcinoma: a pooled data analysis of two phase III trials. J Clin Oncol 23(6):1118–1124

    Article  CAS  PubMed  Google Scholar 

  • Chua DT, Ma J, Sham JS, et al (2006) Improvement of survival after addition of induction chemotherapy to radiotherapy in patients with early-stage nasopharyngeal carcinoma: subgroup analysis of two phase III trials. Int J Radiat Oncol Biol Phys 65(5):1300–1306

    Article  PubMed  Google Scholar 

  • Chua DT, Sham JS, Choy D, et al (1998) Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma. Asian-Oceanian Clinical Oncology Association Nasopharynx Cancer Study Group. Cancer 83(11):2270–2283

    Article  CAS  PubMed  Google Scholar 

  • Cvitkovic E, Eschwege F, Rahal M, et al (1996) Preliminary results of trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs radiotherapy alone in stage IV (≥N2, M0) undifferenti-ated nasopharyngeal carcinoma: a positive effect on progression free survival. Int J Radiat Oncol Biol Phys 35:463–469

    Article  CAS  Google Scholar 

  • Decker DA, Drelichman A, Al-Sarraf M, et al (1983) Chemotherapy for nasopharyngeal carcinoma. A ten-year experience. Cancer 52:602–605

    Article  CAS  PubMed  Google Scholar 

  • Dimery IW, Goepfert J P, Morrison WH, et al (1993) Effectiveness of combined induction chemotherapy and radiotherapy in advanced nasopharyngeal carcinoma. J Clin Oncol 11(10):1919–1928

    CAS  PubMed  Google Scholar 

  • Geara FB, Glisson BS, Sanguineti G, et al (1997) Induction chemotherapy followed by radiotherapy versus radiotherapy alone in patients with advanced nasopharyngeal carcinoma. Cancer 79(7):1279–1286

    Article  CAS  PubMed  Google Scholar 

  • Greene F, Page D, Fleming I (eds) (2002) AJCC cancer staging manual, 6th edn. Springer, New York

    Google Scholar 

  • Hara W, Loo BW, Goffinet DR, et al (2008) Excellent local control with stereotactic radiotherapy boost after external beam radiotherapy in patients with nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 71(2):393–400

    Article  PubMed  Google Scholar 

  • Hareyama M, Sakata K, Shirato H, et al (2002) A prospective, randomized trial comparing neoadjuvant chemotherapy with radiotherapy alone in patients with advanced nasopharyngeal carcinoma. Cancer 94(8):2217–2223

    Article  CAS  PubMed  Google Scholar 

  • Hong RL, Ting LL, Ko JY, et al (2001) Induction chemotherapy with mitomycin, epirubicin, cisplatin, fluorouracil, and leu-covorin followed by radiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma. J Clin Oncol 19(23):4305–4313

    CAS  PubMed  Google Scholar 

  • Hong S, Wu HG, Chie EK, et al (1999) Neoadjuvant chemotherapy and radiation therapy compared with radiation therapy alone in advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 45(4):901–905

    Article  CAS  PubMed  Google Scholar 

  • Hui E P, Ma BB, Leung SF, et al (2009) Randomized phase II trial of cisplatin-radiotherapy with and without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinoma. J Clin Oncol 27(2):242–249

    Article  CAS  PubMed  Google Scholar 

  • Jian JJ, Cheng SH, Tsai SY, et al (2002) Improvement of local control of T3 and T4 nasopharyngeal carcinoma by hyper-fractionated radiotherapy and concomitant chemotherapy. Int J Radiat Oncol Biol Phys 53:344–352

    Article  PubMed  Google Scholar 

  • Johnson FM, Garden A, Palmer JL, et al (2004) A phase II study of docetaxel and carboplatin as neoadjuvant therapy for nasopharyngeal carcinoma with early T status and advanced N status. Cancer 100(5):991–998

    Article  CAS  PubMed  Google Scholar 

  • Johnson FM, Garden AS, Palmer JL, et al (2005) A phase I-II study of neoadjuvant chemotherapy followed by radiation with boost chemotherapy for advanced T-classification nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 63:717–724

    Article  CAS  PubMed  Google Scholar 

  • Khoury GG, Paterson ICM (1987) Nasopharyngeal carcinoma: a review of cases treated by radiotherapy and chemotherapy. Clin Radiol 38:17–20

    Article  CAS  PubMed  Google Scholar 

  • Kwong DL, Sham JS, Au GK, et al (2004) Concurrent and adjuvant chemotherapy for nasopharyngeal carcinoma: a factorial study. J Clin Oncol 22(13):2643–2653

    Article  CAS  PubMed  Google Scholar 

  • Lee AW, Lau KY, Hung WM, et al (2008) Potential improvement of tumor control probability by induction chemotherapy for advanced nasopharyngeal carcinoma. Radiother Oncol 87:204–210

    Article  CAS  PubMed  Google Scholar 

  • Lee AW, Lau WH, Tung SY, et al (2005a) Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group. J Clin Oncol 23:6966–6975

    Article  CAS  PubMed  Google Scholar 

  • Lee AW, Sze WM, Au SK, et al (2005b) Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience. Int J Radiat Oncol Biol Phys 61:1107–1116

    Article  PubMed  Google Scholar 

  • Lee AW, Tung SY, Chan AT, et al (2006) Preliminary results of a randomized study (NPC-9902 Trial) on therapeutic gain by concurrent chemotherapy and/or accelerated fractionation for locally-advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 66:142–151

    Article  PubMed  Google Scholar 

  • Lee AW, Yau TK, Wong HM, et al (2005c) Treatment of stage IV(A–B) nasopharyngeal carcinoma by induction-concurrent chemoradiotherapy and accelerated fraction-ation. Int J Radiat Oncol Biol Phys 63:1331–1338

    Article  PubMed  Google Scholar 

  • Lee N, Xia P, Quivey JM, et al (2002) Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys 53(1):12–22

    Article  PubMed  Google Scholar 

  • Lin JC, Chen KY, Jan JS, et al (1996) Partially hyperfractionated accelerated radiotherapy and concurrent chemotherapy for advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 36:1127–1136

    Article  CAS  PubMed  Google Scholar 

  • Ma BB, Tannock IF, Pond GR, et al (2002) Chemotherapy with gemcitabine-containing regimens for locally recurrent or metastatic nasopharyngeal carcinoma. Cancer 95:2516–2523

    Article  CAS  PubMed  Google Scholar 

  • Ma J, Mai HG, Hong MH, et al (2001) Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy versus radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma. J Clin Oncol 19:1350–1357

    CAS  PubMed  Google Scholar 

  • Ngan RK, Yiu HH, Lau WH, et al (2002) Combination gemcit-abine and cisplatin chemotherapy for metastatic or recurrent nasopharyngeal carcinoma: report of a phase II study. Ann Oncol 13:1252–1258

    Article  CAS  PubMed  Google Scholar 

  • Oh JL, Vokes EE, Kies MS, et al (2003) Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal cancer. Ann Oncol 14:564–569

    Article  CAS  PubMed  Google Scholar 

  • Richman SP, Livingston RB, Gutterman JU, et al (1976) Chemotherapy versus chemoimmunotherapy of head and neck cancer: report of a randomized study. Cancer Treat Rep 60:535–539

    CAS  PubMed  Google Scholar 

  • Rischin D, Corry J, Smith J, et al (2002) Excellent disease control and survival in patients with advanced nasopharyngeal cancer treated with chemoradiation. J Clin Oncol 20:1845–1852

    Article  CAS  PubMed  Google Scholar 

  • Sobin L (2002) International Union Against Cancer (UICC): TNM classification of malignant tumors, 6th edn. Wiley, New York

    Google Scholar 

  • Tannock I, Payne D, Cummings B, et al (1987) Sequential chemotherapy and radiation for nasopharyngeal cancer: absence of long-term benefit despite a high rate of tumor response to chemotherapy. J Clin Oncol 5(4):629–634

    CAS  PubMed  Google Scholar 

  • Webster K, Cella D, Yost K (2003) The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: properties, applications, and interpretation. Health Qual Life Outcomes 1:79–85

    Article  PubMed  Google Scholar 

  • Wee J, Tan EH, Tai BC, et al (2005) Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union Against Cancer Stage III and IV nasopharyngeal cancer of the endemic variety. J Clin Oncol 23:6730–6738

    Article  CAS  PubMed  Google Scholar 

  • Wolden SL, Zelefsky MJ, Kraus DH, et al (2001) Accelerated concomitant boost radiotherapy and chemotherapy for advanced nasopharyngeal carcinoma. J Clin Oncol 19:1105–1110

    CAS  PubMed  Google Scholar 

  • Yau TK, Lee AW, Wong DH, et al (2006b) Treatment of stage IV(A–B) nasopharyngeal carcinoma by induction-concurrent chemoradiotherapy and accelerated fractionation: impact of chemotherapy schemes. Int J Radiat Oncol Biol Phys 66:1004–1010

    Article  CAS  PubMed  Google Scholar 

  • Yau TK, Lee AW, Wong HM, et al (2006a) Induction chemotherapy with cisplatin and gemcitabine followed by accelerated radiotherapy and concurrent cisplatin in patients with stage IV(A–B) nasopharyngeal carcinoma. Head Neck 28:880–887

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Oncology, Pamela Youde Nethersole Eastern Hospital, 3 Lok Man Road, Chai Wan, Hong Kong, SAR, P.R. China

    Anne W. M. Lee

Authors
  1. Anne W. M. Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Radiation Oncology, National University Cancer Institute of Singapore National University Health System National University of Singapore, 5 Lower Kent Ridge Road, Singapore, 119074, Republic of Singapore

    J. J. Lu (Associate Professor and Consultant, Distinguished Clinical Professor) (Associate Professor and Consultant, Distinguished Clinical Professor)

  2. Fudan University Shanghai Cancer Center, 270 Dong An Road, Shanghai, 200232, P.R. China

    J. J. Lu (Associate Professor and Consultant, Distinguished Clinical Professor) (Associate Professor and Consultant, Distinguished Clinical Professor)

  3. Department of Radiation Oncology, Maimonides Cancer Center, 6300 Eighth Avenue, Brooklyn, NY, 11220, USA

    J. S. Cooper (Professor and Chairman) (Professor and Chairman)

  4. Department of Clinical Oncology, Pamela Youde Nethersole Eastern Hospital, 3 Lok Man Road, Chai Wan, Hong Kong SAR, P.R. China

    A. W. M. Lee

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Lee, A.W.M. (2010). Neoadjuvant Chemotherapy: Trials and Conclusions. In: Lu, J.J., Cooper, J.S., Lee, A.W.M. (eds) Nasopharyngeal Cancer. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-92810-2_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-92810-2_14

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-92809-6

  • Online ISBN: 978-3-540-92810-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation